David E Scheim

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Respiratory Syndrome Coronavirus

Angiotensin Converting Enzyme

Top Venues

International journal of molecular sciences

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

David E Scheim, Peter I Parry, David J Rabbolini, Colleen Aldous, Morimasa Yagisawa, Robert Clancy, Thomas J Borody, Wendy E Hoy
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses. Viruses 16 (4) (2024)
David E Scheim, Peter I Parry, David J Rabbolini, Colleen Aldous, Morimasa Yagisawa, Robert Clancy, Thomas J Borody, Wendy E Hoy
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses. Viruses 16 (4) (2024)
David E Scheim, Peter I Parry, David J Rabbolini, Colleen Aldous, Morimasa Yagisawa, Robert Clancy, Thomas J Borody, Wendy E Hoy
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses. Viruses 16 (4) (2024)
David E Scheim, Peter I Parry, David J Rabbolini, Colleen Aldous, Morimasa Yagisawa, Robert Clancy, Thomas J Borody, Wendy E Hoy
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses. Viruses 16 (4) (2024)
Paola Vottero, Scott Tavernini, Alessandro D Santin, David E Scheim, Jack Adam Tuszynski, Maral Aminpour
Computational Prediction of the Interaction of Ivermectin with Fibrinogen. International journal of molecular sciences 24 (14) (2023)
David E Scheim, Colleen Aldous, Barbara Osimani, Edmund J Fordham, Wendy E Hoy
When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three Examples. Journal of clinical medicine 12 (11) (2023)
David E Scheim, Paola Vottero, Alessandro D Santin, Allen G Hirsh
Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19. International journal of molecular sciences 24 (23) (2023)
Celine Boschi, David E Scheim, Audrey Bancod, Muriel Militello, Marion Le Bideau, Philippe Colson, Jacques Fantini, Bernard La Scola
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects. International journal of molecular sciences 23 (24) (2022)
Celine Boschi, David E Scheim, Audrey Bancod, Muriel Militello, Marion Le Bideau, Philippe Colson, Jacques Fantini, Bernard La Scola
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects. International journal of molecular sciences 23 (24) (2022)
Celine Boschi, David E Scheim, Audrey Bancod, Muriel Militello, Marion Le Bideau, Philippe Colson, Jacques Fantini, Bernard La Scola
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects. International journal of molecular sciences 23 (24) (2022)
David E Scheim
A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. International journal of molecular sciences 23 (5) (2022)
Celine Boschi, David E Scheim, Audrey Bancod, Muriel Militello, Marion Le Bideau, Philippe Colson, Jacques Fantini, Bernard La Scola
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects. International journal of molecular sciences 23 (24) (2022)